InvestorsHub Logo
Followers 3
Posts 104
Boards Moderated 0
Alias Born 07/15/2016

Re: andy55q post# 8483

Friday, 04/07/2017 8:42:03 AM

Friday, April 07, 2017 8:42:03 AM

Post# of 27409
Andy, interesting development with latest case report -- from Russia -- Noted that "Use of CytoSorb in complex therapy of generalized meningococcal infection, septic shock and MOF in a pediatric patient" case report came from Russia. And, the patient was a young child. Very encouraging that Russian docs are beginning to discover CytoSorb. Plus, the influence and reach of Fresenius is obvious throughout the report. It makes me wonder if ICU docs consult with Fresenius during critical situations and if Fresenius makes the recommendation to introduce CytoSorb. This would suggest that Fresenius has an incredibly high level of confidence in CytoSorb. Also makes me wonder if they put up the $10MM in an eye blink last week?? Thanks for posting these case reports. Very revealing...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News